Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma
Clinical trial NCT05677217 · UNKNOWN
Trial details
- NCT number
- NCT05677217
- Sponsor
- CHA University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-20
- Primary completion
- 2024-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.